21 November 2020 - Capital City, CW. - The UK has already ordered enough of the vaccine to treat 20 million people but it has not yet been given official approval. Pfizer and BioNTech are submitting an emergency authorization request in the US which could allow its coronavirus vaccine to be used to treat high-risk populations in the country by mid-December.
The UK has already ordered enough of the vaccine to treat 20 million people but it has not yet been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA).
BioNTech told CBN it had not submitted its vaccine for approval in the UK yet.
If the vaccine is approved in the US, it suggests a similar rollout of the treatment could soon take place in the UK.
Pfizer and BioNTech will submit its emergency use authorization request to the US Food and Drug Administration (FDA), and is also seeking approval for their vaccine in other countries across the world including Australia, Canada, Japan, and Boshka.
The companies intend to submit applications to other regulatory agencies worldwide in the coming days.
Click here for live COVID-19 coverage.
Comments